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Abstract
Background Gallstones are a major cause of morbidity,
and cholecystectomy is a commonly performed procedure.
Minimal invasive procedures, laparoscopic cholecystec-
tomy (LC) and small-incision cholecystectomy (SIC), have
replaced the classical open cholecystectomy. No differences
have been found in primary outcome measures between LC
and SIC, therefore secondary outcome measures have to be
considered to determine preferences. The aim of our study
was to examine health status applying evidence-based
guidelines in LC and SIC in a randomised trial.
Methods Patients with symptomatic cholecystolithiasis
were included in a blind randomised trial. Operative pro-
cedures, anaesthesia, analgesics and postoperative care
were standardised in order to limit bias. Questionnaires
were filled in preoperatively, the first day postoperatively,
and at outpatients follow-up at 2, 6 and 12 weeks. In
accordance with evidence-based guidelines, the generic
short form (SF-36) and the disease-specific gastrointestinal
quality-of-life index (GIQLI) questionnaires were used in
addition to the body image questionnaire (BIQ).
Results A total of 257 patients were randomised between
LC (120) and SIC (137). Analyses were performed
according to intention-to-treat (converted procedures
included) and also distinguishing converted from minimal
invasive (nonconverted) procedures. Questionnaires were
obtained with a response rate varying from 87.5% preop-
eratively to 77.4% three months postoperatively. Except
for two time-specific measurements in one SF-36 subscale,
there were no differences between LC and SIC. There were
significant differences in several subscales in all three
questionnaires comparing minimal invasive versus con-
verted procedures.
Conclusions Applying adequate methodological quality
and evidence-based guidelines (by using SF-36 and GI-
QLI), there are no significant differences in health status
between LC and SIC.
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Cholecystectomy is a commonly performed procedure in
patients with symptomatic cholecystolithiasis. With an
estimated incidence up to 2.17 per thousand inhabitants
[1, 2], and 500,000 cholecystectomies performed annually
in the USA [3] and 21,000 in The Netherlands (an inci-
dence of 1.31 per thousand inhabitants) [4, 5], gallstones
are a major cause of morbidity in the Western world.
During the 1980s, the preferred surgical technique for
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cholecystectomy changed from the classical open proce-
dure to a smaller incision approach [6, 7] and eventually to
laparoscopic cholecystectomy. Although evidence of
superiority was never delivered, the laparoscopic technique
was accepted as the gold-standard procedure by consensus
[3].
Multiple randomised trials comparing laparoscopic (LC)
and small-incision cholecystectomy (SIC) have been per-
formed and results are inconsistent. Some favour the SIC
technique, others favour the LC technique, and many take a
neutral position. All these randomised trials are included in
our Cochrane review. Our review showed no differences in
primary outcome measures between LC and SIC [8].
In comparing (surgical) treatments, primary outcome
measures (mortality and severe complications) have to be
considered prior to secondary outcome measures. As no
significant differences between LC and SIC in primary
outcome measures were found [8], it is justified to consider
health status, an important secondary outcome measure.
Frequently, quality of life is confused with health status.
Quality of life measures the subjective judgment of patients
about their condition, while health status refers to the
impact of disease on patients’ lives in the physical, psy-
chological and social domains.
Questionnaires, both generic and condition-specific,
have been shown to be useful in measuring changes in
health status after cholecystectomy [9–11]. Several studies
showed that health status was improved, both after LC and
open cholecystectomy in patients suffering socially dis-
abling uncomplicated symptomatic cholecystolithiasis [12–
14]. Differences between the open and laparoscopic tech-
nique are not clear [15], although some studies found
superior results using the laparoscopic technique [16, 17].
To date, differences in health status between LC and
SIC are not very well examined [18–20]. Moreover, as the
previous studies did not use the appropriate questionnaires
as advised by evidence-based guidelines, there had been no
possibility to correctly find differences in health status
between both operating techniques.
The gastrointestinal quality of life index (GIQLI) and
the short form (SF-36) are frequently used and validated
questionnaires (disease-specific and generic, respectively)
and are most suitable for evaluating patients’ functional
recovery after cholecystectomy [21].
Objective
The aim of our study was to examine differences in health
status in patients with symptomatic cholecystolithiasis
before and after LC and SIC in a blinded randomised
clinical trial. We used the GIQLI and the SF-36 question-
naires, as recommended by evidence-based guidelines [21].
Methods
All patients with symptomatic cholecystolithiasis visiting
the outpatients clinic of the St. Elisabeth hospital in Tilburg
were considered for inclusion in a blind randomised trial
comparing laparoscopic and small-incision cholecystec-
tomy. Verbal and written informed consent was obtained
from each patient, and patients were consecutively listed for
elective cholecystectomy. Health status was a secondary
outcome measure as part of the randomised clinical trial.
Sample size
No differences in primary outcome measures (mortality
and complications) were expected between LC and SIC [8].
Consequently, a secondary outcome measure should be
used to decide on preferences between both techniques. We
decided to focus on costs between both techniques as the
most important secondary outcome measure. Based on an
anticipated difference of 10% in direct costs 120 patients
had to be included in each group. However, multiple out-
come measures including health status were evaluated in
this randomised trial.
Based on a previous study [18], it was calculated that
128 patients were needed in each group to detect a dif-
ference of 5 points (assuming a standard deviation of 20) in
the gastrointestinal quality-of-life index (GIQLI) ques-
tionnaire with a type I error of 0.05 and a power of 0.8.
Randomisation
As randomised trials with high bias risk may overestimate
intervention effects [22], results of randomised trials with
low bias risk are considered more reliable. Therefore,
attention is warranted for correct generation of the allo-
cation sequence, allocation concealment, blinding, and
follow-up.
A random-number table was used for the generation of
the allocation sequence and allocation concealment was
guaranteed by using sealed envelopes. To eliminate bias
caused by preoperative expectations, patients were ran-
domised in the operation theatre after induction of
anaesthesia. A telephone call to the secretary office was
made and an employee opened an envelope. All patient
data were recorded in a case record form, with the proce-
dure reported as ‘trial cholecystectomy’. Wounds and port
sites were dressed with identical opaque dressings, stained
using iodine, regardless of the surgical procedure per-
formed, to allow blinding for patient, nurses, and
physicians during the postoperative period. The type of
operation was revealed just before discharge.
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No patients were lost to follow-up. Operative procedures
were standardised apart from using a laparoscopic or small-
incision technique. Anaesthesia, postoperative care and
analgesic use were also standardised.
Inclusion and exclusion criteria
Inclusion criteria were: male or female patients with
symptomatic cholecystolithiasis, age 18 years or older at
recruitment, with reasonable to good health according to
American Society of Anaesthesiologists (ASA) classifica-
tion (ASA I or II) [23], no known relevant allergies and a
signed letter of informed consent.
Exclusion criteria were: age younger than 18 years, cho-
ledocholithiasis (icterus, acholic faeces and/or bilirubine
twice normal range), cholangitis, known pregnancy, mod-
erate to severe systemic disease (ASA III and higher), known
cirrhosis of the liver, history of abdominal malignancy,
previous upper abdominal surgery (precluding laparoscopic
approach), psychiatric disease, or another reason (e.g. lack of
knowledge of the Dutch language) for making follow-up or
completion of questionnaires unreliable.
Obesity was indexed but not considered an exclusion
criterion [24]. Recovery after successful endoscopic treat-
ment of choledocholithiasis was not a contraindication.
Acute cholecystitis is a different disease with other com-
plication rates, morbidity, and conversion rates, and patients
suffering acute cholecystitis were, therefore, not included.
Surgical procedures
The policy in our hospital was not to perform operative
cholangiography in any patient in elective cholecystec-
tomy. All patients had nasogastric intubations during the
operation that were removed immediately afterwards.
Bladder drainage was not performed. Abdominal wall and
skin closure were standardised. In case of technical diffi-
culties or for safety reasons, both laparoscopic and small-
incision cholecystectomies were converted to open chole-
cystectomy by a subcostal incision ([8 cm). Reasons for
conversion were registered. The wounds were covered with
standard wound dressings as described by Majeed [24] to
blind patient and ward personnel postoperatively. We did
not use any local anaesthetic technique into the wounds nor
intercostal nerve blocks.
Laparoscopic cholecystectomy
Open introduction of trocars was performed in all patients,
regardless of previous abdominal surgery. Pneumoperito-
neum was created using the subumbilical trocar with an
intra-abdominal pressure up to 12 mmHg. Three trocars for
instruments were inserted. The dissection of the cystic
artery and cystic duct, identifying Calot’s triangle, was
performed using a three-point ‘flag’ technique [25]. The
cystic duct and artery were clipped and transsected. After
complete dissection of the gallbladder, it was removed
either through the subumbilical or the subxyphoidal trocar.
Fascia defects as a result of the insertion of 10mm trocar
and the open introduction of the subumbilical trocar were
closed with UR6 vicryl 1.0/2.01 sutures. All instruments,
except for the subumbilical trocar, were reusable. No
suction drains were left in the subhepatic space at the end
of the procedure.
Small-incision cholecystectomy
In the literature most authors used 8 cm (or less) as a cut-
off point to differentiate between small-incision and open
cholecystectomy [24, 26–32]. Therefore, we performed
small-incision cholecystectomy principally through an
incision of 6 cm, maximally extended to 8 cm. As part of a
separate research question, all patients had a preoperative
ultrasound scan and the location of the fundus of the
gallbladder was marked on the skin. We used the cranio-
caudal position of the mark for incision. The mediolateral
position of the mark was not used, because in the pilot
phase we found that the incision would be too lateral for
adequate view of the hilus. The incision was placed over
the musculus rectus abdominis. Only standard instruments
were used and no special equipment. Access to the peri-
toneum was obtained by a muscle splitting (and not
transsection) technique of the musculus rectus abdominis
(like in an open appendectomy). The gallbladder was dis-
sected by a fundus-first technique. If necessary the
gallbladder was punctured to remove its liquid contents.
The cystic duct and artery were ligated and the gallbladder
was removed. No suction drains were left in the subhepatic
space at the end of the procedure. Posterior and anterior
fascias were closed separately with PDS 3.01 running
suture. After wound closure, the length of the incision
was measured. When the length exceeded 8 cm, the
operation was considered to be a conversion to open
cholecystectomy.
Postoperative protocol
Early oral intake and mobilization were encouraged.
Patients left the hospital as soon as they felt capable. As
patients were admitted at the day of operation, hospital stay
was defined as the number of nights (postoperative) in
hospital. Shortly before discharge, wound dressings were
Surg Endosc (2008) 22:1649–1659 1651
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removed for wound inspection. For logistic reasons, we
were not able to blind the surgeon at the patients’ follow-
up. Follow-up took place according to a standardised
scheme after 2 weeks, 6 weeks, and 3 months. Patients
were encouraged to resume work and normal daily activity
as soon as they felt capable to do so.
Measurements
In accordance with evidence-based guidelines [21], we
decided to use the generic short form (SF-36) and the
disease-specific gastrointestinal quality-of-life index (GI-
QLI) questionnaires. These questionnaires were completed
preoperatively, on the first day postoperative and at each
follow-up visit after 2 and 6 weeks and after 3 months. In
addition, the body image questionnaire (BIQ) was com-
pleted preoperatively and at 6 weeks postoperatively in
order to estimate differences in the patients’ perception of
their body image and cosmetics [33].
The SF-36 is a generic health status questionnaire that
has 36 questions to assess eight domains (physical func-
tioning, role physical, bodily pain, general health, vitality,
social functioning, role emotional and mental health) [34].
Internal consistency measured by Cronbach’s alpha was
shown to be high (above 0.80 in all subscales) [34]. The
Dutch version has been validated [35].
The GIQLI is a disease-specific health status measure.
It includes both specific questions on gastrointestinal
symptoms, for both the upper and the lower gastrointes-
tinal tract, as well as questions on physical, emotional and
social capabilities [36]. It is a mixed questionnaire that
includes both generic and specific questions. Based on
face validity, five subscales are distinguished in addition
to a total score. Internal consistency measured by Cron-
bach’s alpha was shown to be high (above 0.90 in all
subscales) [36]. The Dutch version has been validated
[37].
The body image questionnaire (BIQ) consists of nine
questions evaluating three subscales: body image, cos-
metic, and self-confidence. The BIQ has shown to consist
of two factors, a body image and a cosmetic factor [33].
The body image scale measures patients’ perception of and
satisfaction with their own body and explores patients’
attitudes toward their bodily appearance. The cosmetic
scale assesses the degree of satisfaction of patients with
respect to the physical appearance of the scar. Additionally,
a question is added to assess patients’ self-confidence
before and after surgery. Internal validity (measured by
Crohnbach’s alpha) reliability coefficients were shown to
be high for both the body image (0.80) and cosmetic scales
(0.83) [33].
Statistical analysis
Analyses were performed according to the type of opera-
tive procedure used, based on the intention to treat
principle. Apart from this main analysis, one subgroup
analysis was performed: converted procedures (LC and
SIC) were compared with minimal invasive procedures
(LC and SIC). This subgroup analysis was performed in
order to illustrate the sensitivity of the questionnaires.
Calculations were made using SPSS version 11.01.
Repeated measures analysis of variance (ANOVA) was
used to evaluate health status differences over time
between the two operative techniques.
Additional independent t-tests were performed to test for
time-specific differences in scores at the preoperative
measurements between two groups in order to check for a
correct randomisation procedure. If appropriate, additional
independent t-tests were performed to test for other time-
specific differences in measurements.
Results
All trial patients were included and operated between Jan-
uary 2001 and March 2004. Leaving unwilling and
excluded patients out of consideration, 366 patients initially
fulfilled the inclusion criteria and were initially included in
the trial. A total of 102 patients were not randomised for a
variety of reasons (Fig. 1). After randomizing 264 patients,
another seven patients were excluded (after their chole-
cystectomy) for the following reasons: unwillingness for
further participation in the trial (2), intraoperative suspicion
of malignancy (2), transfer to another ward not participating
in the trial (1), participation in two trials (not in line with the
Helsinki declaration) (1), and insufficient knowledge of the
Dutch language (1). Excluding the data of these seven
patients from our analyses did not affect the results of our
questionnaires in any way. A total of 257 patients were left
for analysis (LC:120 and SIC:137).
Baseline characteristics and operative results
The groups (LC and SIC) did not differ regarding age, sex,
body mass index (BMI) and ASA classification (Table 1).
The classical diagnostic symptoms of cholecystolithiasis as
well as the duration of these symptoms were also equally
distributed in both groups. In addition, the number of
patients presenting with complicated gallstone disease who
had received treatment by endoscopic retrograde cholan-
giopancreaticography (ERCP) (and papillotomy) were
equally distributed and operated on in a later stage (Table 2).
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There was no mortality. There were five intraoperative
complications in the LC group compared with three in the
SIC group. There were 16 postoperative complications in
the LC group and 13 in the SIC group. There were 21 and
16 total complications (intra- and postoperative) in the LC
and SIC group, respectively. Of these, 11 and 7 compli-
cations were serious in the LC and the SIC group,
respectively (Table 3). We did not find a difference in the
number or severity of the complications.
Operative time was shorter for SIC compared to LC (60
versus 72 min, respectively; U = 6013.0, p \ 0.001).
Conversion rates were similar (p = 0.312), with similar
reasons for conversion. The follow-up rate between the
groups was not statistically different. Follow-up was 91.4–
96.3% at six weeks, 82.2–82.8% at three months and 100%
at either six weeks or three months. Complaints at follow-
up were comparable.
There were no differences in the preoperative mea-
surements of the SF-36 subscales, all the GIQLI subscales,
the total GIQLI score and the BIQ subscales.
Health status
The questionnaires were obtained with a response rate
varying from 87.5% preoperatively to 77.4% three months
Assessed for eligibility (n=366)
Randomised
(n=264)
Excluded (n=102) 
      Waiting list problem (n=30) 
      Refused to participate (n=34) 
      Other reasons (n=38)
Allocated to LC (n=123) 
      Received allocated intervention (n=121) 
      Did not receive allocated intervention 
      (excluded after randomization) (n=2)
Allocated to SIC (n=141) 
      Received allocated intervention (n=141) 
      Did not receive allocated intervention 
      (excluded after randomization) (n=0) 
Lost to follow-up (n=0) 
Discontinued intervention (n=1) 
Lost to follow-up (n=0) 
Discontinued intervention (n=4) 
Analysed (n=120) 
Excluded from analysis (n=0) 
Analysed (n=137) 
Excluded from analysis (n=0) 
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Fig. 1 Revised consort statement diagram showing the flow of participants through each stage of the randomised trial [38]
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postoperatively. The nonresponders did not differ from
those who remained in the study with regard to compli-
cations (16%), operative time (65 minutes), hospital stay
(1.5 days), return to work (3.2 weeks) or baseline scores.
When comparing LC with SIC (intention-to-treat), we
found no differences in all SF-36 subscales, except for
‘perceived health change’. There were significant differ-
ences favouring the laparoscopic technique (F = 16.054, df
= 1; p \ 0.001) (Table 4). Performing time-specific anal-
yses, differences were identified at two weeks (p = 0.029)
and six weeks (p \ 0.001) postoperatively. There were no
differences between LC and SIC with regard to the four
GIQLI subscales, the total GIQLI score, and the body
image subscales.
Subgroup analysis
In checking for differences in preoperative data in the
minimal invasive procedures versus conversions
Table 1 Patient characteristics
Laparoscopic
cholecystectomy
(n = 120)
Small-incision
cholecystectomy
(n = 137)
P
value
Male 31 (25.8%) 30 (21.9%) 0.459
Female 89 (74.2%) 107 (78.1%)
Age (years)
Mean (SD) 48.4 (14.1) 48.5 (14.0) 0.974
Median
(range)
49 (17–77) 48 (18–80)
BMI
Mean (SD) 27.5 (4.8) 27.9 (4.6) 0.500
Median
(range)
26.8 (18.5–45.9) 27,2 (18.0–43.3)
ASA stage
I 81 (67.5%) 91 (66.4%) 0.855
II 39 (32.5%) 46 (33.6%)
BMI body mass index; ASA american society of anaesthesiologists
classification
Table 2 Operative features and
difficulties of laparoscopic and
small-incision cholecystectomy
# conversions were included in
incision length measurements
* hospital stay in postoperative
nights
Laparoscopic
cholecystectomy
(n = 120)
Small-incision
cholecystectomy
(n = 137)
P value
Patients with complicated
gallstone diseases
before cholecystectomy
18 18 0.668
Endoscopic retrograde
cholangiopancreaticography
12 13 0.890
Duration of symptoms (weeks) n = 107 (89.2%) n = 130 (94.9%) 0.443
mean (SD) 61.1 (108.8) 70.3 (147.2)
median (range) 26 (2–884) 17.5 (1–1040)
Incision length (mm) # n = 95 (12
conversions)
n = 134
(20 conversions)
0.196
mean (SD) 76.1 (33.8) 76.0 (24.0)
median (range) 65 (40–200) 66 (49–165)
Inflammation 21 25 0.876
Operative team:
surgeon–resident 15 (12.5%) 21 (15.3%) 0.515
resident–surgeon 84 (70.0%) 100 (73.0%) 0.596
resident–resident 21 (17.5%) 18 (13.1%) 0.331
Hospital stay *
mean (SD) 2.4 (4.6) 3.1 (12.4) 0.560
median (range) 1 (1–36) 2 (1–144)
Hospital stay *
(without one
extreme value)
mean (SD) 2.1 (3.38) 2.04 (2.42) 0.877
Employed (n) 50 51
Return to work (weeks)
mean (SD) 4.1 (2.3) 3.7 (2.0) 0.298
median (range) 4 (1–12) 3 (0.5–12)
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comparison, we only found a significant difference in the
self-confidence subscale of the body image questionnaire (t
= 2.821, df = 207, p = 0.005) with higher self-confidence
scores in the minimal invasive operated group (7.08 versus
6.31). No other differences were found in preoperative
data.
In order to assess differences between minimal invasive
procedures (both laparoscopic and small-incision) and
procedures converted to the classical open cholecystec-
tomy, we examined patients’ scores across the follow-up
period (Table 5).
There were significant differences in the SF-36 sub-
scales ‘physical functioning’ (F = 4.057, df = 1; p = 0.046)
and ‘pain’ (F = 4.391, df = 1; p = 0.038). In the GIQLI
questionnaire, there were significant differences in the total
score (F = 5.593, df = 1; p = 0.020), and in the ‘physical’ (p
= 0.007), ‘social’ (p = 0.003), and ‘mental’ (p = 0.004)
subscales. Also, in the BIQ there were significant differ-
ences in the ‘body image’ and ‘cosmetic’ subscales
between both operative groups, favouring the minimal
invasive procedures (F = 13.939, df = 1; p \ 0.001). No
other differences were found.
Discussion
We have used both generic and disease-specific health
status questionnaires and a body image questionnaire to
evaluate the effect of LC versus SIC in patients having
cholecystectomy for symptomatic cholecystolithiasis. No
differences were found between laparoscopic and small-
incision cholecystectomies (applying intention-to-treat).
However, with regard to minimal invasive or converted
procedures, we found significant differences in the ‘phys-
ical’ subscales in both SF-36 and GIQLI as well as
differences in body image in favour of minimal invasive
procedures. The fact that significant differences were found
in the ‘physical’ subscales in both questionnaires illustrates
construct validity between both health status instruments.
Literature
A few other studies have compared health status after LC
and SIC [18–20]. Two studies found that the laparoscopic
technique was associated with a more rapid improvement
in health status after cholecystectomy compared with the
small-incision technique [18, 19]. One study found no
differences at all between both techniques [20]. However,
it is difficult to draw conclusions from three studies that
used different questionnaires and suffer several methodo-
logical flaws. None of the mentioned studies combined the
SF-36 and GIQLI as advised by evidence-based guidelines
[21].
Barkun studied 35 and 23 patients in the LC and SIC
groups, respectively, and used the same GIQLI as we did
in addition to the Nottingham health profile (NHP) and a
visual analogue scale (VAS) for health [18]. Allocation
concealment was unclear, no blinding was used, and eight
dropouts occurred in their rather small, preliminary
stopped trial. They used cumulative totals of both GIQLI
and NHP data instead of using subscales. Changes in one
dimension might be offset by changes in other dimen-
sions. Both questionnaires have more than one dimension
(the cumulative total); subscales indeed provide the
advantage of additional information on several dimen-
sions. As a rather small number of patients were included
Table 3 Serious complications in laparoscopic and small-incision
cholecystectomy (intraoperative and postoperative)
Laparoscopic cholecystectomy 11 Small-incision
cholecystectomy
7
Intraoperative complications
Asystole 1 Cardiac ischemia, no
elevated enzymes
1
Common bile duct
(CBD) injury, eventually
hepatico-jejunostomy,
complicated prolonged ICU
stay, stenosis bile duct.
1 CBD injury, conversion,
T-drain, ERCP and
papillotomy for CBD
stone
1
Bleeding requiring conversion
(and transfusion)
1 Hepatic parenchyma
rupture, conservative
treatment (transfusion)
1
Bowel injury at
introduction
(sutured)
1
Cerebrovascular
accident at recovery
1
Total intraoperative 5 Total intraoperative 3
Postoperative complications
Pneumonia 1 Cystic duct leakage
(ERCP + stent)
1
Cerebrovascular accident
(6 weeks postoperative)
1 CBD injury, multiple
relaparotomies and
ICU stay
1
Intra-abdominal fluid
collection (haematoma);
icterus (ERCP: no stones,
complicated by bleeding)
1 CBD stone (ERCP) and
abscess intra-abdominal
(ultrasound drainage)
1
Pancreatitis (conservative
treatment)
1 CBD stone with
pancreatitis (ERCP)
1
Intra-abdominal abscess
(re-laparoscopy)
1
Epididimitis (operation
by urologist)
1
Total postoperative 6 Total postoperative 4
CBD common bile duct; ICU intensive care unit; ERCP endoscopic
retrograde cholangiopancreaticography
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(the trial was stopped preliminary), no subscales were
assessed, and no considerations were given to the con-
struct or divergent validity of both questionnaires, their
conclusion that LC was associated with a significantly
quicker return to ‘good health’ seems inappropriate based
on their results.
McMahon compared health status in 151 and 148 lap-
aroscopic and small-incision cholecystectomy patients
respectively using the SF-36 health survey questionnaire
and the hospital anxiety and depression scale (HADS) [19].
Generation of the allocation sequence in their trial was
unclear and no blinding was used. They found that patients
Table 4 Comparison of GIQLI, SF-36 and BIQ scores in laparoscopic (LC) and small-incision cholecystectomy (SIC) according to intention-to-
treat (mean scores and SD)
Preoperative Postoperative P value
day 1 2 weeks 6 weeks 12 weeks
SF-36
Physical LC 77.0 (23.0) 57.1 (29.5) 67.5 (23.2) 83.2 (21.2) 87.8 (17.4) 0.413
SIC 83.0 (18.3) 39.9 (29.8) 63.0 (22.8) 83.1 (20.8) 87.5 (19.3)
Social LC 43.4 (14.2) 77.8 (19.9) 70.7 (23.9) 86.5 (19.3) 91.9 (15.9) 0.260
SIC 42.7 (17.1) 74.3 (22.6) 66.3 (25.8) 82.3 (22.9) 90.4 (19.0)
Role physical LC 56.4 (43.4) 52.6 (43.2) 26.7 (36.4) 67.4 (40.1) 81.1 (34.9) 0.667
SIC 60.8 (44.4) 53.0 (45.7) 29.5 (49.4) 54.8 (42.6) 79.2 (35.8)
Role emotion LC 73.7 (39.4) 70.5 (38.8) 68.3 (41.7) 82.7 (33.6) 88.6 (27.8) 0.797
SIC 74.3 (39.7) 70.3 (40.7) 66.4 (54.9) 80.7 (36.5) 88.7 (29.4)
Mental LC 61.7 (11.8) 75.0 (17.1) 77.3 (18.3) 83.3 (16.2) 85.1 (16.6) 0.558
SIC 62.0 (10.9) 72.1 (18.9) 74.5 (18.7) 81.2 (18.4) 83.4 (17.4)
Vitality LC 54.1 (11.0) 59.6 (22.4) 52.1 (21.1) 67.8 (20.1) 73.5 (20.4) 0.767
SIC 53.8 (12.2) 58.4 (22.9) 51.8 (21.6) 66.9 (22.6) 72.7 (21.7)
Pain LC 56.5 (19.5) 55.6 (22.5) 52.2 (21.7) 74.7 (20.2) 82.4 (21.5) 0.429
SIC 54.6 (17.1) 55.9 (24.6) 46.4 (21.9) 69.3 (23.8) 83.1 (21.4)
General health LC 56.1 (11.7) 69.7 (17.3) 71.8 (19.3) 74.9 (22.0) 76.3 (21.2) 0.457
SIC 57.4 (11.3) 65.1 (19.2) 70.1 (20.1) 72.5 (21.5) 76.4 (19.2)
Health change LC 57.7 (21.2) 57.7 (21.2) 62.0 (26.9) 76.7 (23.9) 77.1 (24.4) \0.001*
SIC 55.4 (20.4) 55.4 (20.4) 53.5 (27.5) 64.6 (25.1) 71.5 (27.2)
GIQLI
Physical LC 2.79 (0.76) 2.82 (0.73) 2.78 (0.75) 3.20 (0.62) 3.31 (0.59) 0.790
SIC 2.95 (0.74) 2.67 (0.83) 2.69 (0.75) 3.14 (0.73) 3.30 (0.63)
Gastrointestinal LC 3.01 (0.59) 3.01 (0.54) 3.22 (0.48) 3.46 (0.41) 3.50 (0.42) 0.247
SIC 3.12 (0.58) 3.13 (0.55) 3.22 (0.45) 3.46 (0.46) 3.52 (0.40)
Social LC 2.89 (0.48) 2.82 (0.42) 2.81 (0.52) 2.93 (0.37) 2.97 (0.29) 0.056
SIC 2.90 (0.42) 2.82 (0.43) 2.76 (0.56) 2.85 (0.50) 2.85 (0.38)
Mental LC 2.55 (0.55) 2.59 (0.45) 2.88 (0.41) 3.04 (0.35) 3.07 (0.37) 0.561
SIC 2.65 (0.49) 2.58 (0.55) 2.74 (0.45) 2.99 (0.47) 3.04 (0.44)
Total LC 102.4 (17.0) 102.6 (14.8) 108.5 (15.0) 116.4 (11.9) 118.3 (11.7) 0.607
SIC 106.7 (14.9) 104.5 (16.0) 107.4 (14.0) 116.7 (13.2) 118.0 (11.1)
BIQ
Body image LC 6.42 (1.98) – – 6.03 (1.90) – 0.530
SIC 6.26 (1.89) – – 5.85 (1.35) –
Cosmetic LC – – – 18.38 (3.88) – 0.100
SIC – – – 17.52 (3.55) –
Self-confidence LC 6.95 (1.27) – – 7.68 (1.21) – 0.647
SIC 7.02 (1.28) – – 7.49 (1.15) –
* significant difference
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recovering from LC enjoyed significantly better health 1
and 4 weeks after the operation compared with those
recovering from SIC, but no significant difference was
found at 12 weeks. The absence of preoperatively baseline
measurements and the absence of considerations on the
construct or divergent validity of the questionnaires make
conclusions about postoperative data uncertain. Differ-
ences in SF-36 and HADS correlated with differences in
return to domestic and leisure activities, but were not
translated in differences in paid activity.
Squirrell used the NHP in 100 patients (50 in each
group) preoperatively, and 3 weeks and 6 months
Table 5 Comparison of GIQLI, SF-36 and BIQ scores in minimal invasive laparoscopic (LC) and small-incision cholecystectomy (SIC)
procedures versus converted (LC and SIC) procedures (mean scores and SD)
Preoperative Postoperative P value
day 1 2 weeks 6 weeks 12 weeks
SF-36
Physical min-inv 79.9 (21.3) 50.1 (30.9) 67.3 (22.1) 83.5 (21.1) 87.6 (18.9) 0.046*
conv 82.3 (17.5) 31.6 (24.9) 45.5 (22.6) 79.6 (19.3) 87.8 (14.6)
Social min-inv 43.2 (15.5) 76.7 (21.3) 69.9 (24.1) 85.1 (20.9) 90.9 (18.1) 0.214
conv 41.7 (18.3) 70.1 (21.9) 55.1 (29.0) 76.1 (24.7) 93.2 (13.8)
Role physical min-inv 60.2 (43.4) 54.0 (44.5) 27.9 (36.3) 61.3 (41.7) 79.9 (35.2) 0.415
conv 46.9 (46.8) 43.1 (43.9) 31.0 (87.6) 55.0 (44.1) 81.8 (37.1)
Role emotion min-inv 74.9 (39.0) 72.1 (38.8) 67.4 (41.5) 82.1 (34.6) 89.3 (28.1) 0.373
conv 66.7 (42.8) 56.5 (45.4) 66.7 (93.7) 76.7 (40.6) 83.3 (32.1)
Mental min-inv 61.8 (11.6) 73.8 (17.9) 76.6 (17.5) 82.7 (16.4) 84.9 (15.9) 0.413
conv 62.6 (9.1) 70.8 (19.5) 69.0 (25.5) 77.1 (24.4) 78.6 (23.8)
Vitality min-inv 54.0 (11.9) 59.5 (22.8) 53.1 (21.1) 67.8 (21.4) 73.3 (20.6) 0.180
conv 53.2 (8.8) 55.0 (21.2) 41.6 (21.1) 63.3 (21.6) 71.1 (24.9)
Pain min-inv 55.6 (18.4) 56.5 (23.7) 50.4 (22.1) 72.5 (22.3) 82.9 (21.7) 0.038*
conv 55.2 (17.7) 49.6 (22.2) 37.1 (17.4) 65.4 (22.4) 81.9 (18.5)
General health min-inv 56.8 (11.4) 68.2 (18.1) 72.0 (19.4) 74.2 (21.3) 76.9 (19.7) 0.136
conv 56.3 (12.4) 59.7 (19.6) 61.0 (20.2) 67.8 (25.1) 72.2 (23.3)
Health change min-inv 56.8 (20.8) 56.8 (20.8) 58.8 (27.5) 71.7 (24.9) 74.9 (26.3) 0.066
conv 54.2 (20.4) 54.2 (20.4) 46.3 (24.7) 56.3 (24.2) 67.1 (23.6)
GIQLI
Physical min-inv 2.90 (0.72) 2.78 (0.76) 2.79 (0.71) 3.19 (0.65) 3.33 (0.60) 0.007*
conv 2.67 (0.96) 2.40 (0.96) 2.20 (0.87) 2.96 (0.91) 3.10 (0.71)
Gastrointestinal min-inv 3.09 (0.57) 3.10 (0.54) 3.23 (0.47) 3.47 (0.43) 3.52 (0.39) 0.052
conv 2.89 (0.68) 2.89 (0.56) 3.08 (0.37) 3.42 (0.50) 3.46 (0.50)
Social min-inv 2.89 (0.46) 2.83 (0.42) 2.83 (0.51) 2.90 (0.43) 2.92 (0.35) 0.003*
conv 2.90 (0.35) 2.75 (0.45) 2.35 (0.62) 2.74 (0.58) 2.85 (0.35)
Mental min-inv 2.60 (0.53) 2.58 (0.50) 2.84 (0.41) 3.04 (0.38) 3.06 (0.38) 0.031*
conv 2.63 (0.45) 2.64 (0.53) 2.48 (0.57) 2.81 (0.70) 2.96 (0.63)
Total min-inv 104.9 (16.0) 104.3 (15.0) 108.9 (14.3) 117.1 (11.5) 118.4 (11.0) 0.020*
conv 101.4 (17.0) 97.8 (17.8) 98.5 (13.3) 111.2 (19.5) 115.8 (14.0)
BIQ
Body image min-inv 6.31 (1.80) - - 5.75 (1.27) - \0.001*
conv 6.60 (2.78) - - 7.55 (3.04) -
Cosmetic min-inv - - - 18.27 (3.54) - \0.001*
conv - - - 14.86 (3.97) -
Self-confidence min-inv 7.08 (1.16) - - 7.60 (1.13) - 0.064
conv 6.31 (1.83) - - 7.38 (1.60) -
* significant difference; min-inv: minimal invasive procedures (LC and SIC); conv: converted procedures (LC and SIC)
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postoperatively [20]. This was the only study that used
blinding in their methods. Generation of the allocation
sequence in their trial was unclear. At no time there was a
significant difference between the two groups. The study
used a rather small sample size, and unfortunately they did
not use a disease-specific questionnaire, but only one
generic questionnaire. They concluded that it is necessary
to take a broader view of health and not concentrate simply
on pain when assessing postoperative recovery.
In our study, no significant differences were found
between LC and SIC using both generic and disease-spe-
cific health status as well as body image with response in
approximately 80% of patients. The response rate of 77.4%
at 3 months follow-up may represent a possible source of
bias. However, the nonresponders were comparable to
those who remained in the study with regard to compli-
cations, operative time, hospital stay, return to work, and
baseline scores of questionnaires. Moreover, our response
rate is in line with the response rates in the studies of
Barkun et al. (58%) and McMahon et al. (78%).
We conclude that there are no differences between both
operative techniques regarding health status. The only
exception is that in the SF-36 subscale perceived health
change we found a difference between LC and SIC, which
appeared to be caused by the scores at 2 and 6 weeks
postoperatively and disappeared at 3 months follow-up. LC
patients reported a larger health change. However, in the
evaluation of 17 aspects of health status, only one differ-
ence was found. Moreover, this difference in perceived
health change was not reflected in an earlier return to work
in LC. In contrast, SIC patients returned to work quicker
than LC patients, although this different was not signifi-
cant. Therefore, our overall interpretation is that there are
no differences between LC and SIC.
The comparable ‘physical’ subscales in SF-36 and GI-
QLI, which are supposed to measure the same effect, are
both significantly different in the minimal invasive versus
conversions comparison illustrating construct validity of
both questionnaires. Subscales on different subjects in the
questionnaires illustrate divergent validity. Significant
differences between minimal invasive and converted pro-
cedures illustrate that the questionnaires used are able to
measure what they are intended to do.
Conclusion
In our randomised trial with adequate generation of the
allocation sequence, concealment of allocation, blinding,
and follow-up we used both a generic and a disease-spe-
cific questionnaire in addition to a body image
questionnaire. There is no significant difference in health
status measured with SF-36, GIQLI, and BIQ between
laparoscopic and small-incision cholecystectomy (applying
the intention-to-treat principle). Additional calculations
showed a significant difference between minimal invasive
LC or SIC procedures and procedures converted to the
classical open cholecystectomy.
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